|Bid||542.50 x 900|
|Ask||544.00 x 1100|
|Day's range||539.18 - 552.43|
|52-week range||441.00 - 686.62|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||9.81|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||690.00|
Is (REGN) Outperforming Other Medical Stocks This Year?
Here's why they selected Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Viatris (NASDAQ: VTRS). Prosper Junior Bakiny (Regeneron Pharmaceuticals): Shares of Regeneron dropped like a rock amid September's broad market declines.
Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.